OpenURL Connection Search

Select item for more details and to access through your institution.

Combining Hepatic Percutaneous Perfusion with Ipilimumab plus Nivolumab in advanced uveal melanoma (CHOPIN): study protocol for a phase Ib/randomized phase II trial.
Published in:
2022
By:
- Tong, T. M. L.;
- van der Kooij, M. K.;
- Speetjens, F. M.;
- van Erkel, A. R.;
- van der Meer, R. W.;
- Lutjeboer, J.;
- van Persijn van Meerten, E. L.;
- Martini, C. H.;
- Zoethout, R. W. M.;
- Tijl, F. G. J.;
- Blank, C. U.;
- Burgmans, M. C.;
- Kapiteijn, E.
Publication type:
journal article
Correction to: Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases.
Published in:
2024
By:
- Tong, T. M. L.;
- Fiocco, M.;
- van Duijn-de Vreugd, J. J.;
- Lutjeboer, J.;
- Speetjens, F. M.;
- Tijl, F. G. J.;
- Sitsen, M. E.;
- Zoethout, R. W. M.;
- Martini, C. H.;
- Vahrmeijer, A. L.;
- van der Meer, R. W.;
- van Rijswijk, C. S. P.;
- van Erkel, A. R.;
- Kapiteijn, E.;
- Burgmans, M. C.
Publication type:
Correction Notice
Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases.
Published in:
CardioVascular & Interventional Radiology, 2024, v. 47, n. 6, p. 741, doi. 10.1007/s00270-024-03713-0
By:
- Tong, T. M. L.;
- Fiocco, M.;
- van Duijn-de Vreugd, J. J.;
- Lutjeboer, J.;
- Speetjens, F. M.;
- Tijl, F. G. J.;
- Sitsen, M. E.;
- Zoethout, R. W. M.;
- Martini, C. H.;
- Vahrmeijer, A. L.;
- van der Meer, R. W.;
- van Rijswijk, C. S. P.;
- van Erkel, A. R.;
- Kapiteijn, E.;
- Burgmans, M. C.
Publication type:
Article
Combining Melphalan Percutaneous Hepatic Perfusion with Ipilimumab Plus Nivolumab in Advanced Uveal Melanoma: First Safety and Efficacy Data from the Phase Ib Part of the Chopin Trial.
Published in:
CardioVascular & Interventional Radiology, 2023, v. 46, n. 3, p. 350, doi. 10.1007/s00270-022-03338-1
By:
- Tong, T. M. L.;
- Burgmans, M. C.;
- Speetjens, F. M.;
- van Erkel, A. R.;
- van der Meer, R. W.;
- van Rijswijk, C. S. P.;
- Jonker-Bos, M. A.;
- Roozen, C. F. M.;
- Sporrel-Blokland, M.;
- Lutjeboer, J.;
- van Persijn van Meerten, E. L.;
- Martini, C. H.;
- Zoethout, R. W. M.;
- Tijl, F. G. J.;
- Blank, C. U.;
- Kapiteijn, E.
Publication type:
Article

Found: 4

Combining Hepatic Percutaneous Perfusion with Ipilimumab plus Nivolumab in advanced uveal melanoma (CHOPIN): study protocol for a phase Ib/randomized phase II trial.

Correction to: Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases.

Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases.

Combining Melphalan Percutaneous Hepatic Perfusion with Ipilimumab Plus Nivolumab in Advanced Uveal Melanoma: First Safety and Efficacy Data from the Phase Ib Part of the Chopin Trial.